Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital
NCT ID: NCT04812821
Last Updated: 2022-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1177 participants
OBSERVATIONAL
2021-04-12
2022-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Detection of Anaemia During the Maternity
NCT00827463
Evaluation of the Impact of Implementing a Patient Blood Management Protocol on the Transfusion Rate in Delivery Hemorrhage
NCT06916832
Prevalence Study of the Etiology of Pregnancy Anemia
NCT03448432
Health Practice of Hemophilia Patiente Care During Pregnancy, Delivery and Newborn Children
NCT03360149
Iron Metabolism Parameters At First Trimester and preGnancy outcomE
NCT03176147
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire
questionnaire post delivery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Delivery at Nord Franche-Comte Hospital
* Delivery ≥ 32 weeks of amenorrhea
* Informed patient and non-opposition of participation
Exclusion Criteria
* Medical interruption of pregnancy
* Patients with fetal death in utero or neonatal death
* Minor patients
* Premature delivery before 32 weeks
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hopital Nord Franche-Comte
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Nord Franche-Comté
Trévenans, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.